Cofinimmo — Capital/Financing Update 2021

Mar 4, 2021

REGULATED – INSIDE INFORMATION Brussels, embargo until 04.03.2021, 07:40 PM CET

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN.

Cofinimmo announces the successful placement of new shares via accelerated bookbuilding of approximately 180 million EUR

As announced on 03.03.2021, Cofinimmo SA (the "company") (Euronext Brussels: COFB) launched a capital increase in cash via accelerated bookbuilding (the "ABB") with international institutional investors, within the authorised capital, with cancellation of the preferential subscription right of existing shareholders and without granting an irreducible allocation right to existing shareholders (the "capital increase").

The company can now confirm that it has successfully completed the ABB. 1,487,603 new shares, which corresponds to approximately 5.5% of the outstanding capital prior to the capital increase, were placed with institutional investors at an issue price of 121.00 EUR per share. The issue price represents a discount of 4.3% compared with the last trading price on 03.03.2021 of 126.40 EUR per share. The gross amount of the capital increase amounts to approximately 180 million EUR.

The net proceeds will finance Cofinimmo's growth in European healthcare real estate, by refinancing investments completed over the past few months and by supporting further investments in the form of acquisitions and developments. The company has a development pipeline of healthcare properties in Europe amounting to 447 million EUR of which 358 million EUR remaining to be funded in the period 2021 through to 2023.

The issue, delivery and admission to trading on the Euronext Brussels regulated market of the new shares are expected to take place on 08.03.2021.

Trading of Cofinimmo shares was suspended as a result of this ABB and shall resume today, as of the start of trading.

Belfius Kepler Cheuvreux, BNP Paribas Fortis, Goldman Sachs International and ING acted as Joint Global Coordinators and Joint Bookrunners. KBC Securities, Barclays Bank Ireland, Joh. Berenberg, Gossler & Co. and Société Générale acted as Joint Bookrunners.

Jean-Pierre Hanin, CEO of Cofinimmo: "Cofinimmo carried out its first capital increase through accelerated bookbuilding. This successful capital increase of approximately 180 million EUR demonstrates the confidence of the equity markets in Cofinimmo's strategy. With the proceeds, we will continue our strong growth strategy in high quality European healthcare real estate."

REGULATED – INSIDE INFORMATION Brussels, embargo until 04.03.2021, 07:40 PM CET

PRESS RELEASE

For more information:

Jochem Binst Lynn Nachtergaele Head of External Communication & IR Investor Relations Officer Tel.: +32 2 373 60 32 Tel.: +32 2 777 14 08 jbinst@cofinimmo.be lnachtergaele@cofinimmo.be

About Cofinimmo:

Cofinimmo has been acquiring, developing and managing rental properties for over 35 years. The company has a portfolio spread across Belgium, France, the Netherlands, Germany, Spain, Finland and Ireland with a value of approximately 4.9 billion EUR. With attention to social developments, Cofinimmo has the mission of making high-quality care, living and working environments available to its partners-tenants, from which users benefit directly. 'Caring, Living and Working - Together in Real Estate' is the expression of this mission. Thanks to its expertise, Cofinimmo has built up a healthcare real estate portfolio of approximately 2.9 billion EUR in Europe.

As an independent company that applies the highest standards of corporate governance and sustainability, Cofinimmo offers its tenants services and manages its portfolio through a team of over 140 employees in Brussels, Paris, Breda and Frankfurt.

Cofinimmo is listed on Euronext Brussels (BEL20) and benefits from the REIT system in Belgium (RREC), France (SIIC) and the Netherlands (FBI). Its activities are supervised by the Financial Services and Markets Authority (FSMA), the Belgian regulator.

On 24.02.2021, Cofinimmo's total market capitalisation stood at approximately 3.5 billion EUR. The company applies an investment policy aimed at offering a socially responsible, long-term, low-risk investment that generates a regular, predictable and growing dividend.

REGULATED – INSIDE INFORMATION Brussels, embargo until 04.03.2021, 07:40 PM CET

PRESS RELEASE

Disclaimer:

This press release is not intended for publication, distribution or release, directly or indirectly, in or into the United States (including its territories and possessions, any state of the United States and the District of Columbia), Canada, Australia, Japan, South Africa or any other jurisdiction in violation of the relevant laws of such jurisdiction.

This press release is not in any manner intended to constitute (nor will there be) an offer to sell or subscribe for, or the announcement of a forthcoming offer to sell or subscribe for, or a solicitation of any offer to buy or subscribe for, or the announcement of a forthcoming solicitation of any offer to buy or subscribe for any of the company's securities in, or towards residents, inhabitants, or citizens of the United States, Canada, Australia, Japan, South Africa or of any jurisdiction where such offering or solicitation is not permitted without registration, exemption from registration or qualification under the applicable legislation of the relevant jurisdiction, or does not meet the required conditions under the applicable legislation of the relevant jurisdiction.

The company's securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "US Securities Act"), or with any other securities regulatory authority of any state or other jurisdiction in the United States. The company's securities may not be offered, sold, resold, transferred or delivered, directly or indirectly, within the United States except pursuant to an applicable exemption from the registration requirements of the US Securities Act and in compliance with any applicable securities laws of any state or jurisdiction of the United States. There will be no public offer of securities in the United States.

This press release may only be distributed (A) outside the United States in accordance with Regulation S under the US Securities Act to (i) persons inside the United Kingdom (a) having professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), or (b) who are high net worth entities falling within Article 49(2)(a) to (d) of the Order, or (c) to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any securities of the company or any member of its group may otherwise lawfully be communicated or caused to be communicated; (ii) persons in Belgium and other member states of the European Economic Area who are "qualified investors" within the meaning of Article 2(e) of the Prospectus Regulation (Regulation (EU) 2017/1129, as amended); (iii) professional investors (as such term is defined in the Swiss Financial Services Act ("FinSA")) in Switzerland or otherwise on the basis of applicable exemptions from the prospectus requirements under the FinSA; (iv) certain qualified and/or institutional investors in other selected jurisdictions, in accordance with applicable restrictions; and (B) persons in the United States who are "qualified institutional buyers", as defined in and in reliance on, Rule 144A under the US Securities Act or another available exemption from, or in a transaction not subject to, registration under the US Securities Act.

The company cannot be held liable should the above restrictions be breached by any person.